表紙
市場調查報告書

帶原者篩檢的全球市場 (∼2024年):擴大帶原者篩檢 (預先設計型、定制型)、標的疾病帶原者篩檢

Carrier Screening Market by Product and Service, Type (Expanded Carrier (Predesigned, Customized), Targeted Disease Carrier), Medical Condition (Pulmonary, Hematological), Technology (Sequencing, PCR), End User, Region - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 916831
出版日期 內容資訊 英文 149 Pages
訂單完成後即時交付
價格
Back to Top
帶原者篩檢的全球市場 (∼2024年):擴大帶原者篩檢 (預先設計型、定制型)、標的疾病帶原者篩檢 Carrier Screening Market by Product and Service, Type (Expanded Carrier (Predesigned, Customized), Targeted Disease Carrier), Medical Condition (Pulmonary, Hematological), Technology (Sequencing, PCR), End User, Region - Global Forecast to 2024
出版日期: 2019年11月14日內容資訊: 英文 149 Pages
簡介

全球帶原者篩檢的市場在預測期間內預計將以17.5%的年複合成長率 (CAGR) 發展,從2019年的18億美元,成長到2024年40億美元的規模。對疾病的早期發現、預防的焦點擴大,染色體異常的高風險性,技術的發展等要素促進該市場的成長。

本報告提供全球帶原者篩檢的市場調查,市場定義和概要,市場成長的各種影響因素及市場機會分析,各產品&服務、類型、疾病區分、技術、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等資訊彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 機會
    • 課題

第6章 帶原者篩檢市場分析、預測:各產品、服務

  • 簡介
  • 服務
  • 產品

第7章 帶原者篩檢市場分析、預測:各類型

  • 簡介
  • 擴大帶原者篩檢
    • 預先設計型面板檢驗
    • 定制型面板檢驗
  • 標的疾病帶原者篩檢

第8章 帶原者篩檢市場分析、預測:各疾病種類

  • 簡介
  • 肺部疾病
  • 血液疾病
  • 神經疾病
  • 其他

第9章 帶原者篩檢市場分析、預測:各技術

  • 簡介
  • DNA定序
  • 聚合酵素鏈鎖反應
  • 微陣列
  • 其他

第10章 帶原者篩檢市場分析、預測:各終端用戶

  • 簡介
  • 醫院
  • 參考實驗室
  • 醫生的辦公室、診療所
  • 其他

第11章 帶原者篩檢市場分析、預測:各地區、主要國家

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第12章 競爭環境

  • 簡介
  • 市場排行榜
  • 競爭領導製圖
  • 競爭模式

第13章 企業簡介

  • INVITAE CORPORATION
  • FULGENT GENETICS
  • SEMA4
  • EUROFINS SCIENTIFIC
  • OPKO HEALTH
  • QUEST DIAGNOSTICS INCORPORATED
  • MYRIAD GENETICS
  • ILLUMINA
  • THERMO FISHER SCIENTIFIC
  • LUMINEX CORPORATION
  • NATERA
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • BGI
  • GENE BY GENE
  • PROGENITY
  • OTOGENETICS CORPORATION
  • CENTOGENE
  • PATHWAY GENOMICS
  • MEDGENOME
  • TRUE HEALTH

第14章 附錄

目錄
Product Code: MD 7435

"Increasing emphasis on early disease detection and prevention is expected to drive the growth of the global carrier screening market."

The global carrier screening market size is expected to grow from USD 1.8 billion in 2019 to USD 4.0 billion by 2024, at a CAGR of 17.5% during the forecast period. Growth in the carrier screening market can primarily be attributed to factors such as increasing emphasis on early disease detection and prevention, the high risk of chromosomal abnormalities, and technological advancements in carrier screening, such as the introduction of expanded carrier screening panels. The increasing awareness of carrier screening is expected to provide a wide range of growth opportunities for players in the market.

"The expanded carrier screening segment is expected to grow at the highest CAGR during the forecast period."

On the basis of type, the carrier screening market is segmented into targeted disease screening and expanded carrier screening, which includes predesigned and customized carrier screening panel testing. The growth of this segment can be attributed to factors such as the increasing use of new high-throughput technologies such as sequencing & microarrays and recommendations for the use of expanded carrier screening.

"In 2018, the hospitals segment accounted for the largest share of the carrier screening market."

On the basis of end user, the carrier screening market is segmented into hospitals, physician offices and clinics, reference laboratories, and other end users (blood banks, donor banks, community clinic laboratories, and non-profit organizations). In 2018, hospitals formed the largest end-user segment in the carrier screening market. Generally, gynecologists suggest couples to undergo carrier screening tests before and after pregnancy. In such cases, it is observed that gynecologists give reference for genetic counselors, who generally practice at hospitals. As a result, the awareness about hospital-based carrier screening tests is higher among patients than those offered at reference laboratories or at physician offices and clinics. Also, hospitals offer flexibility to patients in terms of sample collection, scheduling specimen pickups, and rapid turnaround time to produce results.

"North America to grow at the highest CAGR during the forecast period."

North America is expected to grow at the highest rate during the forecast period, followed by Europe. This growth can be attributed to several factors, such as the presence of well-established healthcare systems in the US and Canada, wide access to advanced screening techniques (such as DNA sequencing), recommendations for carrier screening, high and growing demand for the early detection of genetic disorders among the population, availability of mass genetic testing programs, increasing number of awareness campaigns, and the high incidence of chromosomal disorders.

In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the carrier screening market.

  • By Respondent Type: Supply-side: 80%, Demand-side: 20%
  • By Designation: C-level Executives: 27%, Directors: 18%, and Others: 55%
  • By Region: North America: 50%, Europe: 20%, APAC: 15%, and RoW: 15%

The carrier screening market comprises major players such as Illumina (US), Natera (US), Fulgent Genetics (US), Sema4 (US), Invitae (US), and LabCorp (US). The study includes an in-depth competitive analysis of these key players in the market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the carrier screening market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on the product & service, medical conditions, technology, condition, type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall carrier screening market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
  • 1.4 YEARS COVERED FOR THE STUDY
  • 1.5 CURRENCY
  • 1.6 LIMITATIONS
  • 1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.2 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CARRIER SCREENING MARKET OVERVIEW
  • 4.2 EUROPE: CARRIER SCREENING MARKET SHARE, BY TYPE AND COUNTRY (2019)
  • 4.3 CARRIER SCREENING MARKET, BY MEDICAL CONDITION
  • 4.4 CARRIER SCREENING MARKET, BY TECHNOLOGY (USD MILLION) (2019 VS 2024)
  • 4.5 CARRIER SCREENING MARKET, BY END USER (USD MILLION) (2019 VS 2024)

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing emphasis on early disease detection and prevention
      • 5.2.1.2 High risk of chromosomal abnormalities with advancing maternal age
      • 5.2.1.3 Technological advancements
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Increasing awareness of carrier screening
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Lack of skilled professionals
      • 5.2.3.2 Lack of standard guidelines for carrier screening

6 CARRIER SCREENING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 SERVICES
    • 6.2.1 RISING NUMBER OF ACCREDITED LABORATORIES IS THE MAJOR INDICATOR OF MARKET GROWTH
  • 6.3 PRODUCTS
    • 6.3.1 EXPANDING USE OF CARRIER SCREENING TESTS HAS DRIVEN GROWTH IN THE PRODUCTS MARKET

7 CARRIER SCREENING MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 EXPANDED CARRIER SCREENING
    • 7.2.1 PREDESIGNED PANEL TESTING
      • 7.2.1.1 Predesigned panel testing accounts for the largest market share
    • 7.2.2 CUSTOMIZED PANEL TESTING
      • 7.2.2.1 Customized panels allow for specific sets of conditions to be screened
  • 7.3 TARGETED DISEASE CARRIER SCREENING
    • 7.3.1 INTRODUCTION OF PANELS CAPABLE OF SIMULTANEOUSLY SCREENING MULTIPLE CONDITIONS HAS DRIVEN MARKET GROWTH

8 CARRIER SCREENING MARKET, BY MEDICAL CONDITION

  • 8.1 INTRODUCTION
  • 8.2 PULMONARY CONDITIONS
    • 8.2.1 INCREASING AWARENESS ABOUT CYSTIC FIBROSIS AND CUSTOMIZED SERVICES IS LIKELY TO BOOST MARKET GROWTH
  • 8.3 HEMATOLOGICAL CONDITIONS
    • 8.3.1 RISING PREVALENCE OF HEMATOLOGICAL DISORDERS HAS INCREASED THE USE OF EXPANDED CARRIER SCREENING PANELS
  • 8.4 NEUROLOGICAL CONDITIONS
    • 8.4.1 GROWING AWARENESS OF NEUROLOGICAL SCREENING AND PRESENCE OF TARGETED SCREENING PANELS WILL SUPPORT MARKET GROWTH
  • 8.5 OTHER MEDICAL CONDITIONS

9 CARRIER SCREENING MARKET, BY TECHNOLOGY

  • 9.1 INTRODUCTION
  • 9.2 DNA SEQUENCING
    • 9.2.1 INCREASING NEED TO DETECT MULTIPLE GENES SIMULTANEOUSLY IS DRIVING DEMAND FOR NGS
  • 9.3 POLYMERASE CHAIN REACTION
    • 9.3.1 RISING NUMBER OF CARRIER SCREENING TESTS FOR TARGETED CHROMOSOMAL CONDITIONS HAS INCREASED THE USE OF PCR
  • 9.4 MICROARRAYS
    • 9.4.1 CLINICAL VALIDITY OF MICROARRAYS IN CARRIER SCREENING HAS INCREASED THEIR USE IN REFERENCE LABORATORIES
  • 9.5 OTHER TECHNOLOGIES

10 CARRIER SCREENING MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS
    • 10.2.1 HOSPITALS FORM THE LARGEST END-USER SEGMENT IN THE CARRIER SCREENING MARKET
  • 10.3 REFERENCE LABORATORIES
    • 10.3.1 ADVANTAGES OFFERED BY REFERENCE LABORATORIES IN TERMS OF SERVICE COSTS AND TURNAROUND TIME WILL SUPPORT MARKET GROWTH
  • 10.4 PHYSICIAN OFFICES AND CLINICS
    • 10.4.1 A LARGE NUMBER OF PHYSICIAN OFFICES AND CLINICS ARE OUTSOURCING CARRIER SCREENING TESTING SERVICES
  • 10.5 OTHER END USERS

11 CARRIER SCREENING MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 US
      • 11.2.1.1 US was the largest market for carrier screening products and services globally in 2018
    • 11.2.2 CANADA
      • 11.2.2.1 Awareness programs, campaigns, and conferences are promoting carrier screening in Canada
  • 11.3 EUROPE
    • 11.3.1 GERMANY
      • 11.3.1.1 Rising prevalence of genetic disorders to support market growth in Germany
    • 11.3.2 UK
      • 11.3.2.1 High incidence of genetic abnormalities to drive the demand for preconception screening in the UK
    • 11.3.3 FRANCE
      • 11.3.3.1 Government initiatives focused on genomics research are expected to support the growth of the carrier screening market in France
    • 11.3.4 ROE
  • 11.4 ASIA PACIFIC
    • 11.4.1 INCREASING GOVERNMENT SUPPORT WILL AID THE GROWTH OF THIS MARKET
  • 11.5 ROW
    • 11.5.1 ROW ACCOUNTS FOR THE SMALLEST SHARE OF THE GLOBAL MARKET

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 MARKET RANKING ANALYSIS
  • 12.3 COMPETITIVE LEADERSHIP MAPPING (2019)
    • 12.3.1 VENDOR INCLUSION CRITERIA
    • 12.3.2 VISIONARY LEADERS
    • 12.3.3 INNOVATORS
    • 12.3.4 DYNAMIC DIFFERENTIATORS
    • 12.3.5 EMERGING COMPANIES
  • 12.4 COMPETITIVE SCENARIO
    • 12.4.1 KEY PRODUCT AND SERVICE LAUNCHES
    • 12.4.2 KEY ACQUISITIONS
    • 12.4.3 KEY PARTNERSHIPS AND COLLABORATIONS

13 COMPANY PROFILES

(Business Overview, Products/Services Offered, Recent Developments, and MnM View)*

  • 13.1 INVITAE CORPORATION
  • 13.2 FULGENT GENETICS
  • 13.3 SEMA4
  • 13.4 EUROFINS SCIENTIFIC
  • 13.5 OPKO HEALTH
  • 13.6 QUEST DIAGNOSTICS INCORPORATED
  • 13.7 MYRIAD GENETICS
  • 13.8 ILLUMINA
  • 13.9 THERMO FISHER SCIENTIFIC
  • 13.10 LUMINEX CORPORATION
  • 13.11 NATERA
  • 13.12 LABORATORY CORPORATION OF AMERICA HOLDINGS
  • 13.13 BGI
  • 13.14 GENE BY GENE
  • 13.15 PROGENITY
  • 13.16 OTOGENETICS CORPORATION
  • 13.17 CENTOGENE
  • 13.18 PATHWAY GENOMICS
  • 13.19 MEDGENOME
  • 13.20 TRUE HEALTH

Details on Business Overview, Products/Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 AVAILABLE CUSTOMIZATIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 2: CARRIER SCREENING SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 3: NORTH AMERICA: CARRIER SCREENING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 4: EUROPE: CARRIER SCREENING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 5: CARRIER SCREENING PRODUCTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: NORTH AMERICA: CARRIER SCREENING PRODUCTS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 7: EUROPE: CARRIER SCREENING PRODUCTS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 8: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 9: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 10: EXPANDED CARRIER SCREENING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: NORTH AMERICA: EXPANDED CARRIER SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 12: EUROPE: EXPANDED CARRIER SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 13: PREDESIGNED PANEL TESTING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: NORTH AMERICA: PREDESIGNED PANEL TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 15: EUROPE: PREDESIGNED PANEL TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 16: CUSTOMIZED PANEL TESTING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: NORTH AMERICA: CUSTOMIZED PANEL TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 18: EUROPE: CUSTOMIZED PANEL TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 19: TARGETED DISEASE CARRIER SCREENING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: NORTH AMERICA: TARGETED DISEASE CARRIER SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 21: EUROPE: TARGETED DISEASE CARRIER SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 22: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 23: LIVE BIRTH INCIDENCE OF CYSTIC FIBROSIS
  • TABLE 24: CARRIER SCREENING PRODUCTS/SERVICES FOR CYSTIC FIBROSIS
  • TABLE 25: CARRIER SCREENING MARKET FOR PULMONARY CONDITIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: NORTH AMERICA: CARRIER SCREENING MARKET FOR PULMONARY CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 27: EUROPE: CARRIER SCREENING MARKET FOR PULMONARY CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 28: CARRIER SCREENING MARKET FOR HEMATOLOGICAL CONDITIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: NORTH AMERICA: CARRIER SCREENING MARKET FOR HEMATOLOGICAL CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 30: EUROPE: CARRIER SCREENING MARKET FOR HEMATOLOGICAL CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 31: GLOBAL PREVALENCE OF NEUROLOGICAL CONDITIONS
  • TABLE 32: CARRIER SCREENING PRODUCTS/SERVICES FOR NEUROLOGICAL CONDITIONS
  • TABLE 33: CARRIER SCREENING MARKET FOR NEUROLOGICAL CONDITIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 34: NORTH AMERICA: CARRIER SCREENING MARKET FOR NEUROLOGICAL CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 35: EUROPE: CARRIER SCREENING MARKET FOR NEUROLOGICAL CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 36: CARRIER SCREENING MARKET FOR OTHER MEDICAL CONDITIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 37: NORTH AMERICA: CARRIER SCREENING MARKET FOR OTHER MEDICAL CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 38: EUROPE: CARRIER SCREENING MARKET FOR OTHER MEDICAL CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 39: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 40: SEQUENCING TECHNOLOGIES USED BY MARKET PLAYERS
  • TABLE 41: CARRIER SCREENING MARKET FOR DNA SEQUENCING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 42: NORTH AMERICA: CARRIER SCREENING MARKET FOR DNA SEQUENCING, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 43: EUROPE: CARRIER SCREENING MARKET FOR DNA SEQUENCING, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 44: PCR TECHNOLOGIES USED BY MARKET PLAYERS
  • TABLE 45: CARRIER SCREENING MARKET FOR PCR, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 46: NORTH AMERICA: CARRIER SCREENING MARKET FOR PCR, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 47: EUROPE: CARRIER SCREENING MARKET FOR PCR, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 48: MICROARRAY TECHNOLOGIES USED BY MARKET PLAYERS
  • TABLE 49: CARRIER SCREENING MARKET FOR MICROARRAYS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 50: NORTH AMERICA: CARRIER SCREENING MARKET FOR MICROARRAYS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 51: EUROPE: CARRIER SCREENING MARKET FOR MICROARRAYS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 52: CARRIER SCREENING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 53: NORTH AMERICA: CARRIER SCREENING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 54: EUROPE: CARRIER SCREENING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 55: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 56: CARRIER SCREENING MARKET FOR HOSPITALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 57: NORTH AMERICA: CARRIER SCREENING MARKET FOR HOSPITALS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 58: EUROPE: CARRIER SCREENING MARKET FOR HOSPITALS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 59: CARRIER SCREENING MARKET FOR REFERENCE LABORATORIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 60: NORTH AMERICA: CARRIER SCREENING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 61: EUROPE: CARRIER SCREENING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 62: CARRIER SCREENING MARKET FOR PHYSICIAN OFFICES AND CLINICS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 63: NORTH AMERICA: CARRIER SCREENING MARKET FOR PHYSICIAN OFFICES AND CLINICS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 64: EUROPE: CARRIER SCREENING MARKET FOR PHYSICIAN OFFICES AND CLINICS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 65: CARRIER SCREENING MARKET FOR OTHER END USERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 66: NORTH AMERICA: CARRIER SCREENING MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 67: EUROPE: CARRIER SCREENING MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 68: CARRIER SCREENING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 69: NORTH AMERICA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 70: NORTH AMERICA: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 71: NORTH AMERICA: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 72: NORTH AMERICA: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 73: NORTH AMERICA: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 74: NORTH AMERICA: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 75: NORTH AMERICA: CARRIER SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 76: US: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 77: US: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 78: US: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 79: US: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 80: US: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 81: US: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 82: CANADA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 83: CANADA: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 84: CANADA: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 85: CANADA: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 86: CANADA: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 87: CANADA: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 88: EUROPE: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 89: EUROPE: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 90: EUROPE: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 91: EUROPE: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 92: EUROPE: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 93: EUROPE: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 94: EUROPE: CARRIER SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 95: GERMANY: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 96: GERMANY: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 97: GERMANY: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 98: GERMANY: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 99: GERMANY: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 100: GERMANY: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 101: UK: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 102: UK: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 103: UK: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 104: UK: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 105: UK: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 106: UK: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 107: FRANCE: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 108: FRANCE: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 109: FRANCE: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 110: FRANCE: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 111: FRANCE: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 112: FRANCE: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 113: ROE: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 114: ROE: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 115: ROE: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 116: ROE: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 117: ROE: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 118: ROE: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 119: ASIA PACIFIC: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 120: ASIA PACIFIC: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 121: ASIA PACIFIC: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 122: ASIA PACIFIC: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 123: ASIA PACIFIC: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 124: ASIA PACIFIC: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 125: ROW: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 126: ROW: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 127: ROW: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 128: ROW: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 129: ROW: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 130: ROW: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARIES: CARRIER SCREENING MARKET
  • FIGURE 3: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4: MARKET SIZE ESTIMATION: CARRIER SCREENING MARKET
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2018
  • FIGURE 7: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2018
  • FIGURE 8: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2018
  • FIGURE 9: CARRIER SCREENING MARKET, BY END USER, 2018
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE CARRIER SCREENING MARKET
  • FIGURE 11: RISING GLOBAL GENETIC DISEASE BURDEN AND INCREASING FOCUS ON EARLY CARRIER SCREENING ARE DRIVING THE CARRIER SCREENING MARKET
  • FIGURE 12: GERMANY DOMINATES THE EUROPEAN MARKET FOR CARRIER SCREENING
  • FIGURE 13: PULMONARY CONDITIONS ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2018
  • FIGURE 14: DNA SEQUENCING SEGMENT DOMINATES THE CARRIER SCREENING MARKET
  • FIGURE 15: HOSPITALS TO HOLD THE LARGEST MARKET SHARE DURING 2019-2024
  • FIGURE 16: CARRIES SCREENING MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17: CARRIER SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 18: NORTH AMERICA: CARRIER SCREENING MARKET SNAPSHOT
  • FIGURE 19: ASIA PACIFIC: CARRIER SCREENING MARKET SNAPSHOT
  • FIGURE 20: RANK OF COMPANIES IN THE CARRIER SCREENING MARKET, 2018
  • FIGURE 21: CARRIER SCREENING MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
  • FIGURE 22: INVITAE: COMPANY SNAPSHOT (2018)
  • FIGURE 23: FULGENT GENETICS: COMPANY SNAPSHOT (2018)
  • FIGURE 24: EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2018)
  • FIGURE 25: OPKO HEALTH: COMPANY SNAPSHOT (2018)
  • FIGURE 26: QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2018)
  • FIGURE 27: MYRIAD GENETICS: COMPANY SNAPSHOT (2018)
  • FIGURE 28: ILLUMINA: COMPANY SNAPSHOT (2018)
  • FIGURE 29: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2018)
  • FIGURE 30: LUMINEX: COMPANY SNAPSHOT (2018)
  • FIGURE 31: NATERA: COMPANY SNAPSHOT (2018)
  • FIGURE 32: LABCORP: COMPANY SNAPSHOT (2018)
Back to Top